Results 341 to 350 of about 7,353,326 (373)
Some of the next articles are maybe not open access.
The Lancet, 2021
Breast cancer is still the most common cancer worldwide. But the way breast cancer is viewed has changed drastically since its molecular hallmarks were extensively characterised, now including immunohistochemical markers (eg, ER, PR, HER2 [ERBB2], and proliferation marker protein Ki-67 [MKI67]), genomic markers (eg, BRCA1, BRCA2, and PIK3CA), and ...
Loibl, Sibylle +4 more
openaire +3 more sources
Breast cancer is still the most common cancer worldwide. But the way breast cancer is viewed has changed drastically since its molecular hallmarks were extensively characterised, now including immunohistochemical markers (eg, ER, PR, HER2 [ERBB2], and proliferation marker protein Ki-67 [MKI67]), genomic markers (eg, BRCA1, BRCA2, and PIK3CA), and ...
Loibl, Sibylle +4 more
openaire +3 more sources
Breast Cancer Treatment: A Review
Journal of the American Medical Association (JAMA), 2019Importance Breast cancer will be diagnosed in 12% of women in the United States over the course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed in the United States in 2017. This review focuses on current approaches and
Adrienne G. Waks, E. Winer
semanticscholar +1 more source
The Lancet, 2005
Extract: Breast cancer is a major public-health issue on a global scale. According to estimates in 2002, there were 1,151,298 new cases of breast cancer diagnosed world-wide. Between 1951 and 1990, mortality from breast cancer rates rose but have since fallen in most European countries, noticeably in the UK. In Japan the mortality rates have been lower
U. Veronesi +4 more
openaire +5 more sources
Extract: Breast cancer is a major public-health issue on a global scale. According to estimates in 2002, there were 1,151,298 new cases of breast cancer diagnosed world-wide. Between 1951 and 1990, mortality from breast cancer rates rose but have since fallen in most European countries, noticeably in the UK. In Japan the mortality rates have been lower
U. Veronesi +4 more
openaire +5 more sources
Science, 1987
The HER-2/neu oncogene is a member of the erbB-like oncogene family, and is related to, but distinct from, the epidermal growth factor receptor. This gene has been shown to be amplified in human breast cancer cell lines. In the current study, alterations
D. Slamon +5 more
semanticscholar +1 more source
The HER-2/neu oncogene is a member of the erbB-like oncogene family, and is related to, but distinct from, the epidermal growth factor receptor. This gene has been shown to be amplified in human breast cancer cell lines. In the current study, alterations
D. Slamon +5 more
semanticscholar +1 more source
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
The Journal of the National Comprehensive Cancer NetworkBreast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include recommendations for clinical ...
W. Gradishar +38 more
semanticscholar +1 more source
New England Journal of Medicine, 1980
TWELVE years ago in the Journal, Dr. F. D. Moore and his colleagues evaluated the various forms of therapy then current for the treatment of both primary and metastatic breast carcinoma.1 In 1967 most patients with breast cancer were treated initially with mastectomy, and at the time of relapse one of various endocrine treatments was employed.
Marc E. Lippman, Joseph C. Allegra
openaire +3 more sources
TWELVE years ago in the Journal, Dr. F. D. Moore and his colleagues evaluated the various forms of therapy then current for the treatment of both primary and metastatic breast carcinoma.1 In 1967 most patients with breast cancer were treated initially with mastectomy, and at the time of relapse one of various endocrine treatments was employed.
Marc E. Lippman, Joseph C. Allegra
openaire +3 more sources
The American Journal of Surgery, 1973
Abstract A consecutive series of 457 patients with breast cancer is reviewed. Tumor size, duration, and extent of nodal involvement are very important factors in prognosis. We continue to believe that so-called radical mastectomy is the surgical procedure of choice in suitable patients because of the finding of 30 per cent positive nodes in ...
John D. Coe, Charles W. McLaughlin
openaire +2 more sources
Abstract A consecutive series of 457 patients with breast cancer is reviewed. Tumor size, duration, and extent of nodal involvement are very important factors in prognosis. We continue to believe that so-called radical mastectomy is the surgical procedure of choice in suitable patients because of the finding of 30 per cent positive nodes in ...
John D. Coe, Charles W. McLaughlin
openaire +2 more sources